To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene VPS16andPTPRATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
619 representative clones for gene VPS16andPTPRA back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BE242232 leukopheresis .a 1 to 273 1 to 273   tiling clone,   273/273
(100 %)
6 diff
(97.9 %id)
BM146804 leukopheresis .a 1 to 543 1 to 543       543/543
(100 %)
7 diff
(98.8 %id)
TI_57179920   .a 12 to 812 30 to 829       800/829
(96 %)
14 diff
(98.4 %id)
BQ213498 melanotic melanoma, skin .a 14 to 552 1 to 546       546/871
(62 %)
9 diff
(99.0 %id)
CN483115 eye .a 16 to 604 1 to 589       589/589
(100 %)
3 diff
(99.5 %id)
BM549486 astrocytoma grade IV, cell line, brain .a 16 to 698 1 to 687       687/1221
(56 %)
7 diff
(99.5 %id)
CX756395 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 17 to 705 1 to 689       685/845
(81 %)
5 diff
(99.5 %id)
BI909955 leukocyte .a 18 to 572 1 to 573       573/1016
(56 %)
38 diff
(96.3 %id)
TI_57237051   .a 18 to 572 89 to 661       573/1104
(51 %)
40 diff
(96.4 %id)
BQ277671 ovary, teratocarcinoma, cell line .a 19 to 974 1 to 960       960/1072
(89 %)
10 diff
(99.1 %id)
BU845142 ovary, teratocarcinoma, cell line .a 19 to 867 1 to 856       856/858
(99 %)
8 diff
(99.1 %id)
CB594513 Blood, promyelocytic leukemia .a 20 to 691 1 to 682       682/905
(75 %)
16 diff
(98.3 %id)
NM_022575.2   .a 26 to 2750 1 to 2725   RefSeq, AAA   2725/2725
(100 %)
0 diff
(100 %id)
BX402036   .a 40 to 1051 1 to 1014   tiling clone,   1014/1014
(100 %)
13 diff
(98.8 %id)
AF308801   .a 69 to 2750 10 to 2691   tiling clone, AAA   2682/2682
(100 %)
4 diff
(99.9 %id)
CR608979 Neuroblastoma Cot 50-normalized .a 87 to 1144 1 to 1058       1058/1058
(100 %)
0 diff
(100 %id)
BX376776 Neuroblastoma Cot 50-normalized .a 87 to 1090 1 to 993       993/1016
(97 %)
10 diff
(99.1 %id)
CD631484   .a 460 to 1333 882 to 9       874/882
(99 %)
5 diff
(99.5 %id)
AL834401 brain .a 508 to 2750 1 to 2243   tiling clone, available from DKFZ, AAA   2243/2243
(100 %)
0 diff
(100 %id)
CD631485   .a 545 to 1331 797 to 10       788/797
(98 %)
1 diff
(99.9 %id)
BG436888 large cell carcinoma, lung .a 591 to 1240 1 to 664       659/923
(71 %)
28 diff
(97.0 %id)
BQ070914 brain, neuroblastoma, cell line .a 665 to 1547 1 to 883       883/1009
(87 %)
2 diff
(99.9 %id)
BE900852 choriocarcinoma, placenta .a 687 to 1098 1 to 410       410/410
(100 %)
2 diff
(99.6 %id)
BE392829 endometrium, adenocarcinoma cell line, uterus .a 692 to 1159 13 to 494       482/499
(96 %)
22 diff
(95.6 %id)
BG764593 melanotic melanoma, high MDR (cell line), skin .a 697 to 1120 1 to 424       424/424
(100 %)
4 diff
(99.1 %id)
BG767960 melanotic melanoma, high MDR (cell line), skin .a 731 to 1120 1 to 391       391/391
(100 %)
9 diff
(97.7 %id)
BG751085 eye, normal pigmented retinal epithelium .a 785 to 1120 1 to 336       336/336
(100 %)
1 diff
(99.8 %id)
BI116241 lung, small cell carcinoma .a 787 to 1120 1 to 334       334/334
(100 %)
1 diff
(99.8 %id)
BG333402 large cell carcinoma, lung .a 816 to 1120 1 to 306       306/306
(100 %)
2 diff
(99.4 %id)
AV694716 hepatocellular carcinoma .a 820 to 1447 1 to 628       626/679
(92 %)
30 diff
(95.6 %id)
DN993802 brain, whole brain .a 1072 to 1660 2 to 590       589/590
(99 %)
2 diff
(99.7 %id)
CN392791 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1189 to 1634 1 to 446       446/446
(100 %)
0 diff
(100 %id)
H38361 eye, retina .a 1285 to 1488 1 to 206       206/206
(100 %)
4 diff
(98.1 %id)
AA018356 eye, retina .a 1287 to 1754 1 to 472       472/476
(99 %)
10 diff
(97.9 %id)
AJ705698 bone marrow .a 1288 to 1764 1 to 477       477/477
(100 %)
1 diff
(99.8 %id)
AV748924 Pituitary .a 1315 to 1868 1 to 545       545/550
(99 %)
9 diff
(98.4 %id)
BC012422 Ovary, adenocarcinoma .a 1345 to 2749 1 to 1405   available from MGC, AAA   1405/1405
(100 %)
8 diff
(99.5 %id)
BF038833 adenocarcinoma, ovary .a 1366 to 2083 1 to 713   available from MGC,   713/757
(94 %)
10 diff
(98.7 %id)
H40633 eye, retina .a 2310 to 2696 392 to 1       392/392
(100 %)
10 diff
(97.5 %id)
AA017123 eye, retina .a 2360 to 2751 392 to 1       392/392
(100 %)
2 diff
(99.5 %id)
DC319280 brain .b 1 to 477 1 to 477   tiling clone,   477/477
(100 %)
0 diff
(100 %id)
DB481544 hippocampus .b 9 to 465 1 to 456       456/463
(98 %)
6 diff
(98.8 %id)
DC353480 brain .b 15 to 570 1 to 556       556/556
(100 %)
0 diff
(100 %id)
DB500708 hypothalamus .b 15 to 461 1 to 449       449/449
(100 %)
5 diff
(98.9 %id)
DB506656 hypothalamus .b 15 to 488 1 to 474       474/474
(100 %)
0 diff
(100 %id)
DC375750 brain .b 15 to 376 1 to 363       363/363
(100 %)
2 diff
(99.5 %id)
DC375753 brain .b 15 to 598 1 to 584       584/584
(100 %)
0 diff
(100 %id)
AK294499 amygdala .b 48 to 2979 1 to 2932 exact tiling clone,   2932/2932
(100 %)
0 diff
(100 %id)
DC317901 amygdala .b 48 to 645 1 to 599       599/599
(100 %)
1 diff
(99.9 %id)
CX865424 embryonic stem .b 75 to 931 1 to 857       857/857
(100 %)
0 diff
(100 %id)
DC375085 brain .b 261 to 818 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
BI763334 pooled colon, kidney, stomach .c 1 to 819 1 to 819   tiling clone,   819/821
(99 %)
8 diff
(99.1 %id)
TI_57150000   .c 1 to 819 68 to 886       819/888
(92 %)
11 diff
(98.8 %id)
BX391063   .c 566 to 1481 1 to 913   tiling clone,   913/913
(100 %)
13 diff
(98.6 %id)
BX372515   .c 614 to 1471 860 to 6       854/860
(99 %)
6 diff
(99.4 %id)
M34668   .c 1270 to 4873 10 to 3613 exact tiling clone,   3604/3615
(99 %)
14 diff
(99.7 %id)
T09271   .c 1274 to 1648 1 to 376       376/376
(100 %)
1 diff
(99.8 %id)
NM_002836.3   .c 1281 to 4899 1 to 3619 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3619/3619
(100 %)
0 diff
(100 %id)
DA796829 brain .c 1846 to 2400 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA699303   .c 1853 to 2367 2 to 516   capped   515/515
(100 %)
1 diff
(99.9 %id)
DN991574 brain, whole brain .c 1889 to 2368 8 to 487       480/487
(98 %)
0 diff
(100 %id)
DA389271 thalamus .c 1938 to 2514 2 to 578   tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
CN350403 embryonic stem cells, DMSO-treated H9 cellline .c 1954 to 2270 1 to 317       317/317
(100 %)
0 diff
(100 %id)
DA274118 corpus callosum .c 1996 to 2414 2 to 420   capped   419/419
(100 %)
0 diff
(100 %id)
DA302889 hippocampus .c 2000 to 2576 2 to 578   capped   577/579
(99 %)
2 diff
(99.7 %id)
DA497010 brain .c 2001 to 2570 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA491248 brain .c 2105 to 2678 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA946139 Spleen .c 2116 to 2670 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA197687 brain .c 2161 to 2715 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA386597 thalamus .c 2161 to 2736 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA503871 brain .c 2259 to 2814 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA685302   .c 2259 to 2799 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA776548 brain .c 2358 to 2932 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
AK297647 brain .c 2390 to 4588 1 to 2199       2199/2199
(100 %)
2 diff
(100.0 %id)
DC354074 brain .c 2390 to 2973 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
DA702865   .c 2411 to 2916 2 to 507   capped   506/506
(100 %)
1 diff
(99.9 %id)
DB001064 breast, tumor tissue .c 2413 to 2969 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
BG031774 breast, mammary adenocarcinoma, cell line .c 2424 to 3118 1 to 696       696/972
(71 %)
20 diff
(98.0 %id)
DB169890 kidney, tumor tissue .c 2456 to 3026 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
BM787606 stomach .c 2458 to 3096 1 to 639       639/639
(100 %)
1 diff
(99.9 %id)
DA166205 amygdala .c 2484 to 3037 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA921854 small intestine .c 2488 to 3065 2 to 579   tiling clone, capped   578/578
(100 %)
0 diff
(100 %id)
DA623883 Kidney .c 2497 to 3041 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA675054   .c 2499 to 3087 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
DA260517 caudate nucleus .c 2501 to 3065 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BM558823 eye, retinoblastoma .c 2516 to 3525 1 to 1018       1018/1018
(100 %)
14 diff
(98.7 %id)
BY796258 eye .c 2562 to 3146 1 to 585       585/585
(100 %)
2 diff
(99.7 %id)
BG741207 skin .c 2562 to 3405 1 to 852       852/860
(99 %)
15 diff
(98.3 %id)
DA153827 amygdala .c 2570 to 3096 2 to 528   capped   527/527
(100 %)
1 diff
(99.9 %id)
BE890223 leiomyosarcoma, uterus .c 2578 to 3299 1 to 719       719/875
(82 %)
19 diff
(97.9 %id)
DB176724 kidney, tumor tissue .c 2608 to 3145 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
CD105953 brain, Pituitary .c 2610 to 3454 26 to 877       852/890
(95 %)
24 diff
(97.4 %id)
BE891248 melanotic melanoma, skin .c 2644 to 3288 1 to 645       645/923
(69 %)
8 diff
(99.2 %id)
BM456575 lymph, lymphoma, cell line .c 2657 to 3422 13 to 781       769/1051
(73 %)
27 diff
(97.5 %id)
CB129091 Liver .c 2670 to 3285 1 to 616       616/616
(100 %)
2 diff
(99.7 %id)
DA170429 amygdala .c 2697 to 3217 2 to 522   capped   521/521
(100 %)
2 diff
(99.7 %id)
DA166883 amygdala .c 2706 to 3249 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA156832 amygdala .c 2757 to 3310 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DA380910 thalamus .c 2761 to 3391 2 to 632   capped   631/631
(100 %)
3 diff
(99.6 %id)
CB155749 brain .c 2763 to 3286 1 to 524       524/524
(100 %)
2 diff
(99.7 %id)
DA299460 hippocampus .c 2768 to 3348 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
DA904732   .c 2772 to 3273 2 to 504   capped   503/503
(100 %)
1 diff
(99.9 %id)
DA709582   .c 2843 to 3411 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA911540   .c 2847 to 3393 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA523979 brain .c 2850 to 3413 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
AU118705 whole embryo, mainly head .c 2867 to 3667 2 to 797   capped   796/801
(99 %)
13 diff
(98.4 %id)
BG390786 embryonal carcinoma, cell line, testis .c 2872 to 3661 1 to 791       791/941
(84 %)
15 diff
(98.5 %id)
BQ130395 insulinoma, Pancreas .c 2872 to 3353 1 to 482       482/482
(100 %)
5 diff
(99.0 %id)
DA063922 cerebellum .c 2910 to 3473 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
CX865222 embryonic stem .c 2911 to 3751 1 to 841       841/841
(100 %)
0 diff
(100 %id)
BG120210 adenocarcinoma, cell line, Liver .c 2912 to 3648 1 to 730       730/969
(75 %)
21 diff
(97.9 %id)
BQ722975 sympathetic trunk .c 2935 to 3741 1 to 812       812/872
(93 %)
13 diff
(98.6 %id)
BE694456 breast .c 2952 to 3569 633 to 18       615/634
(97 %)
6 diff
(99.1 %id)
BX477748   .c 2975 to 3532 1 to 558       558/558
(100 %)
0 diff
(100 %id)
DA942612 Spleen .c 2975 to 3555 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
CB215540 normal endometrium, late proliferativephase, cycle day 13, uterus .c 2981 to 3636 1 to 656       656/656
(100 %)
0 diff
(100 %id)
DA129978 alzheimer cortex .c 2988 to 3614 2 to 628   capped   627/627
(100 %)
0 diff
(100 %id)
BI752012 brain .c 3065 to 3917 1 to 861       861/861
(100 %)
10 diff
(98.9 %id)
TI_57215033   .c 3065 to 3880 73 to 892       820/933
(87 %)
15 diff
(98.4 %id)
CX865180 embryonic stem .c 3067 to 3687 1 to 621     Submitted on the opposite strand 621/621
(100 %)
0 diff
(100 %id)
BG825324 muscle, rhabdomyosarcoma .c 3141 to 3869 1 to 731       731/870
(84 %)
7 diff
(99.2 %id)
DB046909 testis .c 3170 to 3720 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
AV709911 adrenal gland .c 3184 to 3584 1 to 401       401/401
(100 %)
0 diff
(100 %id)
CN350406 embryonic stem cells, DMSO-treated H9 cellline .c 3191 to 3842 1 to 652       652/652
(100 %)
0 diff
(100 %id)
BG176867 lymph, lymphoma, cell line .c 3261 to 4001 1 to 737       737/875
(84 %)
6 diff
(99.4 %id)
BI550275 brain, hippocampus .c 3272 to 3979 5 to 713       709/722
(98 %)
4 diff
(99.5 %id)
BE819013 breast_normal .c 3281 to 3531 1 to 251       251/251
(100 %)
0 diff
(100 %id)
BE819014 breast_normal .c 3281 to 3531 1 to 251       251/251
(100 %)
0 diff
(100 %id)
BE819016 breast_normal .c 3281 to 3531 1 to 251       251/251
(100 %)
0 diff
(100 %id)
BE819018 breast_normal .c 3281 to 3531 1 to 251       251/251
(100 %)
0 diff
(100 %id)
BE830993 marrow .c 3281 to 3392 1 to 112       112/112
(100 %)
0 diff
(100 %id)
BE831001 marrow .c 3281 to 3531 251 to 1       251/251
(100 %)
0 diff
(100 %id)
BE838644 prostate_normal .c 3281 to 3404 1 to 124       124/124
(100 %)
0 diff
(100 %id)
CR623898 Neuroblastoma Cot 50-normalized .c 3303 to 4796 1 to 1494       1494/1494
(100 %)
0 diff
(100 %id)
BX350363   .c 3312 to 4227 916 to 1       916/917
(99 %)
9 diff
(99.1 %id)
BF796807 lymph, lymphoma, cell line .c 3334 to 4002 1 to 667       667/944
(70 %)
5 diff
(99.5 %id)
CR595941 T cells (Jurkat cell line) .c 3346 to 4865 1 to 1520       1520/1520
(100 %)
0 diff
(100 %id)
BX447695 T cells (Jurkat cell line) .c 3346 to 4159 1 to 813       813/922
(88 %)
15 diff
(98.4 %id)
BX464619 T cells (Jurkat cell line) .c 3346 to 4467 1 to 1119       1119/1119
(100 %)
18 diff
(98.4 %id)
BM476531 lymph, lymphoma, cell line .c 3370 to 4399 41 to 1080       1040/1080
(96 %)
28 diff
(97.5 %id)
CD635978   .c 3380 to 3997 614 to 1       614/615
(99 %)
5 diff
(99.2 %id)
TI_1948142276   .c 3417 to 4363 1076 to 127       950/1317
(72 %)
25 diff
(98.2 %id)
TI_1948141949   .c 3420 to 4363 1077 to 129       949/1274
(74 %)
31 diff
(97.6 %id)
CD635976   .c 3422 to 3997 573 to 1       573/575
(99 %)
5 diff
(99.2 %id)
BG674262 skin .c 3422 to 4290 1 to 878       878/1029
(85 %)
16 diff
(98.5 %id)
TI_1948142956   .c 3423 to 4363 1071 to 129       943/1358
(69 %)
26 diff
(98.1 %id)
TI_1948142620   .c 3475 to 4363 1020 to 128       893/1336
(66 %)
20 diff
(98.6 %id)
CD635980   .c 3490 to 3995 505 to 1       505/505
(100 %)
2 diff
(99.7 %id)
DA358587 subthalamic nucleus .c 3525 to 4086 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
CN350395 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 3541 to 4314 1 to 775       775/778
(99 %)
2 diff
(99.8 %id)
CB158537 Liver .c 3547 to 4160 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BM741595 stomach .c 3566 to 4123 1 to 558       558/558
(100 %)
0 diff
(100 %id)
TI_1948141950   .c 3568 to 4363 930 to 131       800/1305
(61 %)
10 diff
(99.3 %id)
BG750594 eye, normal pigmented retinal epithelium .c 3583 to 4415 1 to 837       837/854
(98 %)
20 diff
(97.7 %id)
R71899 breast .c 3591 to 3734 1 to 144       144/144
(100 %)
0 diff
(100 %id)
BM751961 Ascites, stomach .c 3599 to 4091 1 to 493       493/493
(100 %)
0 diff
(100 %id)
CR988094 T-Lymphocytes .c 3600 to 4507 1 to 913       913/914
(99 %)
12 diff
(98.7 %id)
AA372002 muscle .c 3604 to 3910 1 to 307       307/307
(100 %)
0 diff
(100 %id)
BM700462 eye, lens .c 3612 to 4184 1 to 573   fully sequenced, Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 573/573
(100 %)
0 diff
(100 %id)
BE159047 head_neck .c 3636 to 4263 641 to 14     Submitted on the opposite strand 628/641
(97 %)
1 diff
(99.9 %id)
TI_1948142621   .c 3658 to 4363 835 to 129       707/1387
(50 %)
9 diff
(99.4 %id)
BM762149 myeloma .c 3662 to 4369 1 to 708       708/708
(100 %)
0 diff
(100 %id)
BM844646 lymph node, stomach .c 3676 to 4200 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
CN350407 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 3683 to 4228 1 to 546       546/547
(99 %)
3 diff
(99.5 %id)
BF793410 adrenal cortex carcinoma, cell line, adrenal gland .c 3706 to 4377 1 to 674       674/898
(75 %)
8 diff
(99.2 %id)
CB121645 brain .c 3715 to 4250 1 to 536       536/536
(100 %)
1 diff
(99.9 %id)
TI_1948142277   .c 3735 to 4363 743 to 111       633/1295
(48 %)
9 diff
(99.4 %id)
BF966725 brain, hippocampus .c 3741 to 4542 802 to 1       802/819
(97 %)
15 diff
(98.2 %id)
TI_149286411   .c 3742 to 4597 934 to 87   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 848/1084
(78 %)
14 diff
(98.8 %id)
BX101111 multiple sclerosis lesions .c 3749 to 4579 1 to 833       833/833
(100 %)
2 diff
(99.8 %id)
DN602359 human embryonic stem cells .c 3769 to 4582 1 to 814       814/814
(100 %)
0 diff
(100 %id)
N45506 multiple sclerosis lesions .c 3781 to 3994 1 to 214       214/221
(96 %)
1 diff
(99.6 %id)
BM822670 stomach .c 3793 to 4270 1 to 478       478/478
(100 %)
3 diff
(99.4 %id)
BQ719092 sympathetic trunk .c 3810 to 4516 1 to 714       714/858
(83 %)
16 diff
(98.2 %id)
F11788 brain, total brain .c 3818 to 4159 1 to 342       342/346
(98 %)
6 diff
(98.3 %id)
CD366295 Alveolar Macrophage, lung .c 3835 to 4585 767 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 743/749
(99 %)
3 diff
(99.6 %id)
CB243533 Human Lung Epithelial cells, lung .c 3836 to 4536 717 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 701/701
(100 %)
3 diff
(99.6 %id)
CA309381 Alveolar Macrophage, lung .c 3852 to 4597 763 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 747/745
(100 %)
12 diff
(98.4 %id)
BQ773483 Chondrosarcoma Cell line .c 3872 to 4589 734 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 716/726
(98 %)
4 diff
(99.5 %id)
CK005049 brain/CNS, Human Brain - Frontal Cortex .c 3874 to 4421 1 to 548       548/548
(100 %)
2 diff
(99.7 %id)
BM512569 insulinoma, Pancreas .c 3881 to 4328 1 to 448   fully sequenced,   448/448
(100 %)
5 diff
(98.9 %id)
TI_149294075   .c 3906 to 4585 778 to 99   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 680/680
(100 %)
2 diff
(99.8 %id)
BM971994 lung .c 3918 to 4597 698 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 680/680
(100 %)
1 diff
(99.9 %id)
BM984991 lung .c 3927 to 4585 677 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 659/659
(100 %)
2 diff
(99.7 %id)
BG748658 eye, normal pigmented retinal epithelium .c 3943 to 4709 1 to 764       764/769
(99 %)
6 diff
(99.3 %id)
BM700664 eye, eye anterior segment .c 3944 to 4215 1 to 272     Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 272/272
(100 %)
2 diff
(99.3 %id)
BQ003764 Chondrosarcoma, Left Pelvis .c 3969 to 4589 639 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 621/621
(100 %)
0 diff
(100 %id)
BM698951 eye, fetal eyes .c 3985 to 4465 1 to 481       481/481
(100 %)
0 diff
(100 %id)
W00647 multiple sclerosis lesions .c 3997 to 4429 1 to 422   fully sequenced,   422/422
(100 %)
3 diff
(99.3 %id)
TI_159723044   .c 4000 to 4899 955 to 62   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 894/989
(90 %)
15 diff
(98.5 %id)
BM565564 insulinoma, Pancreas .c 4014 to 4612 622 to 24   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 599/599
(100 %)
1 diff
(99.9 %id)
CB219116 mandible, pooled .c 4014 to 4591 627 to 49   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 579/579
(100 %)
4 diff
(99.4 %id)
AU145204 whole embryo, mainly head .c 4022 to 4589 568 to 1       568/568
(100 %)
9 diff
(98.5 %id)
CD513867 brain, Pituitary .c 4078 to 4589 1 to 512   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 512/512
(100 %)
0 diff
(100 %id)
BP424853 small intestine .c 4083 to 4581 1 to 499     Submitted on the opposite strand 499/499
(100 %)
0 diff
(100 %id)
BU947248 insulinoma, Pancreas .c 4099 to 4652 1 to 554       554/554
(100 %)
5 diff
(99.1 %id)
DB571880 hypothalamus .c 4121 to 4584 1 to 464     Submitted on the opposite strand 464/464
(100 %)
2 diff
(99.6 %id)
DB577929 hypothalamus .c 4121 to 4584 1 to 464     Submitted on the opposite strand 464/464
(100 %)
2 diff
(99.6 %id)
BM670576 eye, lens .c 4123 to 4589 485 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 467/467
(100 %)
1 diff
(99.8 %id)
BQ130142 insulinoma, Pancreas .c 4134 to 4680 547 to 1       547/547
(100 %)
2 diff
(99.7 %id)
DB546026 hippocampus .c 4147 to 4589 1 to 443     Submitted on the opposite strand 443/443
(100 %)
3 diff
(99.4 %id)
BU633208 cell lines, Chondrosarcoma .c 4148 to 4899 771 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 753/753
(100 %)
1 diff
(99.9 %id)
TI_149311258   .c 4149 to 4899 829 to 81   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 749/964
(77 %)
8 diff
(99.2 %id)
DB549593 hippocampus .c 4165 to 4612 1 to 448     Submitted on the opposite strand 448/448
(100 %)
0 diff
(100 %id)
AI718863 aorta .c 4180 to 4899 718 to 1       718/718
(100 %)
7 diff
(99.1 %id)
BE895783 melanotic melanoma, skin .c 4184 to 4584 1 to 401       401/401
(100 %)
0 diff
(100 %id)
AW510304 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 4186 to 4598 411 to 1       411/411
(100 %)
2 diff
(99.6 %id)
CB853632 Human Lung Epithelial cells, lung .c 4190 to 4899 728 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 710/710
(100 %)
0 diff
(100 %id)
CA308634 Alveolar Macrophage, lung .c 4196 to 4902 727 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 709/709
(100 %)
2 diff
(99.8 %id)
TI_154057893   .c 4203 to 4899 775 to 89   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 687/906
(75 %)
21 diff
(97.7 %id)
CA309105 Alveolar Macrophage, lung .c 4203 to 4902 715 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 697/699
(99 %)
5 diff
(99.3 %id)
AI002196 Kidney, kidney tumor .c 4242 to 4698 456 to 1       456/456
(100 %)
2 diff
(99.6 %id)
AI860943 anaplastic oligodendroglioma, brain .c 4253 to 4899 650 to 1       650/650
(100 %)
8 diff
(98.8 %id)
FN049529 breast carcinoma .c 4256 to 4343 88 to 1     Submitted on the opposite strand 88/88
(100 %)
0 diff
(100 %id)
CA307513 Alveolar Macrophage, lung .c 4262 to 4899 656 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 638/638
(100 %)
1 diff
(99.9 %id)
CA419463 Bone, Human Chondrosarcoma Cell Line .c 4290 to 4899 626 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 608/608
(100 %)
6 diff
(99.1 %id)
BM691578 eye, RPE and Choroid .c 4293 to 4792 1 to 500       500/500
(100 %)
3 diff
(99.4 %id)
BM512314 insulinoma, Pancreas .c 4298 to 4724 427 to 1   fully sequenced,   427/427
(100 %)
1 diff
(99.8 %id)
BU689311 lung .c 4314 to 4899 605 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 587/587
(100 %)
1 diff
(99.9 %id)
AA429305 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 4322 to 4621 1 to 298   fully sequenced,   298/298
(100 %)
2 diff
(99.4 %id)
AA994434 breast .c 4324 to 4901 578 to 1       578/578
(100 %)
2 diff
(99.7 %id)
BM193070 leukopheresis .c 4325 to 4728 403 to 1       403/403
(100 %)
11 diff
(97.3 %id)
BG741647 skin .c 4329 to 4875 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
AA041424 heart .c 4352 to 4590 1 to 251   fully sequenced,   251/251
(100 %)
3 diff
(98.9 %id)
BQ636609 eye, retina .c 4356 to 4893 1 to 539       539/539
(100 %)
2 diff
(99.7 %id)
AA599125 lung, lung carcinoma .c 4357 to 4701 345 to 1       345/345
(100 %)
0 diff
(100 %id)
BP388881 pancreatic islet .c 4366 to 4901 1 to 536   AAA Submitted on the opposite strand 536/536
(100 %)
0 diff
(100 %id)
AI090208 uterus .c 4394 to 4900 508 to 2       507/508
(99 %)
0 diff
(100 %id)
D55167   .c 4397 to 4776 1 to 380       380/380
(100 %)
2 diff
(99.5 %id)
N63319 multiple sclerosis lesions .c 4399 to 4899 500 to 1   fully sequenced,   500/500
(100 %)
6 diff
(98.8 %id)
BP391926 pancreatic islet .c 4400 to 4899 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
AI096352 uterus .c 4401 to 4900 501 to 2       500/501
(99 %)
0 diff
(100 %id)
AI139084 uterus .c 4406 to 4899 494 to 1       494/494
(100 %)
0 diff
(100 %id)
CA443730 lung, Metastatic Chondrosarcoma .c 4419 to 4899 500 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 482/482
(100 %)
2 diff
(99.6 %id)
N47611 multiple sclerosis lesions .c 4423 to 4899 483 to 1       483/483
(100 %)
8 diff
(98.4 %id)
DB550445 hippocampus .c 4435 to 4899 1 to 466     Submitted on the opposite strand 466/467
(99 %)
2 diff
(99.6 %id)
BQ340882 nervous_normal .c 4438 to 4876 442 to 3       440/442
(99 %)
0 diff
(100 %id)
DB572954 hypothalamus .c 4449 to 4897 1 to 450     Submitted on the opposite strand 450/451
(99 %)
4 diff
(99.2 %id)
AA363943 pineal body .c 4469 to 4740 1 to 272       272/272
(100 %)
0 diff
(100 %id)
BP387928 pancreatic islet .c 4478 to 4866 1 to 390     Submitted on the opposite strand 390/390
(100 %)
1 diff
(99.8 %id)
W20212 parathyroid gland, parathyroid tumor .c 4494 to 4586 1 to 94   fully sequenced, Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 94/94
(100 %)
0 diff
(100 %id)
EC563905 Prostate .c 4552 to 4666 1 to 115       115/115
(100 %)
0 diff
(100 %id)
N90571 parathyroid gland, parathyroid tumor .c 4556 to 4899 362 to 12   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 351/351
(100 %)
5 diff
(98.6 %id)
AA041384 heart .c 4560 to 4899 341 to 1   fully sequenced,   341/341
(100 %)
0 diff
(100 %id)
F09438 brain, total brain .c 4566 to 4902 337 to 1       337/337
(100 %)
1 diff
(99.8 %id)
R71900 breast .c 4574 to 4864 291 to 1       291/291
(100 %)
7 diff
(97.6 %id)
AA425101 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 4591 to 4899 309 to 1   fully sequenced,   309/309
(100 %)
0 diff
(100 %id)
CN350402 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 4613 to 4898 1 to 286       286/286
(100 %)
0 diff
(100 %id)
BM672124 eye, eye anterior segment .c 4642 to 4899 276 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 258/260
(99 %)
0 diff
(100 %id)
AA903762 pooled germ cell tumors .c 4693 to 4901 222 to 14   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 209/209
(100 %)
0 diff
(100 %id)
AI659062 Prostate .c 4706 to 4900 195 to 1       195/195
(100 %)
0 diff
(100 %id)
T28842 brain .c 4731 to 4899 169 to 1       169/169
(100 %)
0 diff
(100 %id)
N95635 lung .c 4736 to 4899 164 to 1       164/164
(100 %)
0 diff
(100 %id)
DA093032 cerebellum .d 1 to 567 2 to 569   tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
DA125626 cerebellum .d 2 to 579 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
BX571753 lymph node .d 2 to 3048 1 to 3047 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3047/3047
(100 %)
1 diff
(100.0 %id)
DB477413 hippocampus .d 35 to 529 1 to 495       495/495
(100 %)
1 diff
(99.8 %id)
BG718885 testis .e 1 to 670 1 to 685   tiling clone,   681/685
(99 %)
17 diff
(97.6 %id)
BI822677 pooled brain, lung, testis .e 5 to 766 1 to 784       784/785
(99 %)
28 diff
(96.5 %id)
BQ213974 melanotic melanoma, skin .e 5 to 778 1 to 781       781/939
(83 %)
21 diff
(97.8 %id)
TI_57198775   .e 5 to 766 36 to 819       780/820
(95 %)
16 diff
(98.1 %id)
NM_080840.2   .e 5 to 3314 1 to 3310 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3310/3310
(100 %)
0 diff
(100 %id)
AW630229 2 pooled high-grade transitional celltumors, genitourinary tract .e 6 to 469 1 to 464       464/501
(92 %)
16 diff
(96.9 %id)
CA389661 eye, RPE/choroid .e 10 to 674 1 to 665       665/665
(100 %)
0 diff
(100 %id)
CR985836 T-Lymphocytes .e 10 to 845 1 to 836       836/836
(100 %)
0 diff
(100 %id)
DA995736 synovial membrane tissue from rheumatioidarthritis .e 13 to 308 2 to 297   capped   296/296
(100 %)
2 diff
(99.4 %id)
AL045069 testis .e 26 to 316 1 to 291       291/291
(100 %)
0 diff
(100 %id)
BG717102 testis .e 26 to 660 1 to 640       636/640
(99 %)
6 diff
(99.1 %id)
BG719849 testis .e 26 to 767 1 to 752       748/752
(99 %)
29 diff
(96.2 %id)
DC348472   .e 27 to 333 1 to 309       309/309
(100 %)
2 diff
(99.4 %id)
DA126301 cerebellum .e 28 to 627 2 to 602   capped   601/601
(100 %)
3 diff
(99.6 %id)
DB100490 testis .e 32 to 609 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA234797 brain .e 46 to 637 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
AI356368 B-cell, chronic lymphotic leukemia .e 49 to 269 220 to 1       220/220
(100 %)
1 diff
(99.6 %id)
DB501756 hypothalamus .e 53 to 521 1 to 469       469/469
(100 %)
0 diff
(100 %id)
DB077686 testis .e 53 to 338 2 to 287   capped   286/286
(100 %)
0 diff
(100 %id)
AU131939   .e 54 to 801 2 to 751   capped   750/750
(100 %)
3 diff
(99.6 %id)
DA124952 cerebellum .e 57 to 617 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
AK290233 thalamus .e 66 to 3150 1 to 3085 exact tiling clone,   3085/3085
(100 %)
1 diff
(100.0 %id)
DA418105 thalamus .e 67 to 545 2 to 480   capped   479/479
(100 %)
0 diff
(100 %id)
TI_57221454   .e 68 to 708 33 to 693       657/1042
(63 %)
29 diff
(97.3 %id)
DA186464 amygdala .e 76 to 574 2 to 500   capped   499/499
(100 %)
1 diff
(99.8 %id)
BU145837 dorsal root ganglia .e 88 to 789 16 to 725       710/985
(72 %)
24 diff
(97.6 %id)
DB480802 hippocampus .e 96 to 600 1 to 506       506/506
(100 %)
1 diff
(99.9 %id)
DB480906 hippocampus .e 96 to 569 1 to 475       475/475
(100 %)
1 diff
(99.8 %id)
CN350408 embryonic stem cells, cell lines H1, H7, andH9 .e 105 to 739 1 to 635       635/635
(100 %)
0 diff
(100 %id)
CN350399 embryonic stem cells, cell lines H1, H7, andH9 .e 114 to 466 1 to 357       357/357
(100 %)
2 diff
(99.5 %id)
CN350398 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 129 to 640 1 to 512       512/512
(100 %)
0 diff
(100 %id)
CN350401 embryonic stem cells, cell lines H1, H7, andH9 .e 130 to 709 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DR003961 Liver .e 190 to 945 1 to 760       756/760
(99 %)
5 diff
(99.4 %id)
BM507302 insulinoma, Pancreas .e 196 to 772 1 to 581       577/581
(99 %)
5 diff
(99.2 %id)
CK905577 insulinoma, Pancreas .e 196 to 766 1 to 575       571/575
(99 %)
5 diff
(99.2 %id)
BC027308 Skin, melanotic melanoma. .e 200 to 3314 1 to 3115 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3115/3115
(100 %)
1 diff
(100.0 %id)
BE892122 melanotic melanoma, skin .e 210 to 812 1 to 610   AAA   606/1099
(55 %)
17 diff
(98.5 %id)
X54890 Kidney .e 212 to 3000 1 to 2788 T114M G280E V358A F484S K777E     2788/2788
(100 %)
9 diff
(99.7 %id)
CA454999   .e 244 to 1102 1 to 867       867/881
(98 %)
12 diff
(98.7 %id)
DB111721 thymus .e 281 to 856 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA388115 thalamus .e 288 to 879 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
BE670805 carcinoid, lung .e 302 to 962 669 to 9       661/669
(98 %)
2 diff
(99.8 %id)
CN350397 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 312 to 1031 1 to 721       721/721
(100 %)
1 diff
(99.9 %id)
DN998309 breast cancer, Mammary gland (cancer tissue) .e 324 to 859 9 to 544       536/544
(98 %)
1 diff
(99.9 %id)
BE219535 carcinoid, lung .e 347 to 900 554 to 1       554/619
(89 %)
9 diff
(98.6 %id)
BY796892 eye .e 356 to 912 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DA745501   .e 363 to 922 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CN350411 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 366 to 1034 1 to 670       670/670
(100 %)
2 diff
(99.8 %id)
X54130 placenta .e 368 to 2797 1 to 2430 exact     2430/2430
(100 %)
1 diff
(100.0 %id)
DA454627 tongue, tumor tissue .e 378 to 880 2 to 504   capped   503/503
(100 %)
0 diff
(100 %id)
AU131514   .e 380 to 1277 2 to 898   capped   897/916
(97 %)
11 diff
(98.8 %id)
BQ436122 epithelioid carcinoma, Pancreas .e 391 to 1260 1 to 873       873/874
(99 %)
14 diff
(98.4 %id)
TI_1948141947   .e 396 to 1195 129 to 930       802/1430
(56 %)
29 diff
(98.0 %id)
TI_1948141948   .e 396 to 1415 119 to 1141       1023/1161
(88 %)
31 diff
(97.4 %id)
TI_1948142274   .e 396 to 1106 128 to 839       712/1404
(50 %)
20 diff
(98.6 %id)
TI_1948142275   .e 396 to 1409 121 to 1139       1017/1279
(79 %)
27 diff
(97.9 %id)
TI_1948142618   .e 396 to 1203 129 to 933       805/1347
(59 %)
32 diff
(97.7 %id)
TI_1948142619   .e 396 to 1409 121 to 1134       1014/1247
(81 %)
22 diff
(98.3 %id)
TI_1948142954   .e 396 to 1036 130 to 770       641/1416
(45 %)
15 diff
(99.0 %id)
TI_1948142955   .e 396 to 1315 119 to 1042       924/1279
(72 %)
21 diff
(98.4 %id)
CV025009 mixed .e 398 to 1007 1 to 610       610/610
(100 %)
0 diff
(100 %id)
DA352090 substantia nigra .e 417 to 970 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BM551238 duodenal adenocarcinoma, cell line, small intestine .e 441 to 1314 1 to 875       875/1112
(78 %)
27 diff
(97.6 %id)
DA944108 Spleen .e 443 to 1013 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA869802 Prostate .e 446 to 968 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
AA489281   .e 470 to 950 1 to 481       481/483
(99 %)
1 diff
(99.8 %id)
DA302901 hippocampus .e 490 to 1061 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA384258 thalamus .e 496 to 1094 2 to 601   capped   600/600
(100 %)
1 diff
(99.9 %id)
DC370580   .e 496 to 963 1 to 469       468/469
(99 %)
3 diff
(99.4 %id)
DB156850 thymus .e 499 to 1074 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BM785900 Ascites, stomach .e 500 to 1038 1 to 539       539/539
(100 %)
2 diff
(99.7 %id)
AW137641   .e 503 to 962 467 to 10       458/467
(98 %)
3 diff
(99.4 %id)
BM829128 Ascites, stomach .e 503 to 892 1 to 390       390/390
(100 %)
7 diff
(98.3 %id)
CN350409 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 527 to 1139 1 to 611       611/611
(100 %)
2 diff
(99.7 %id)
DA499213 brain .e 549 to 1126 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BG260610 bladder, transitional cell papilloma, cell line .e 565 to 1214 1 to 649       649/972
(66 %)
8 diff
(99.2 %id)
BF740139 brain, glioblastoma (pooled) .e 578 to 1160 585 to 1       585/585
(100 %)
18 diff
(97.0 %id)
BU153152 large cell carcinoma, lung .e 583 to 1487 1 to 909       909/909
(100 %)
6 diff
(99.4 %id)
DA769307 brain .e 592 to 1164 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA876451 Prostate .e 603 to 1171 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA367940 subthalamic nucleus .e 606 to 1159 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA160009 amygdala .e 624 to 1203 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
AI953648 Kidney .e 629 to 1160 532 to 1       532/532
(100 %)
2 diff
(99.7 %id)
AW271550 Kidney .e 649 to 1160 512 to 1       512/512
(100 %)
0 diff
(100 %id)
CN350396 embryonic stem cells, DMSO-treated H9 cellline .e 669 to 1270 1 to 603       603/603
(100 %)
1 diff
(99.9 %id)
AI332405 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 671 to 1158 488 to 1       488/488
(100 %)
0 diff
(100 %id)
AI360263 anaplastic oligodendroglioma, brain .e 671 to 1160 490 to 1       490/490
(100 %)
0 diff
(100 %id)
ES310975 scalp interfollicular dermis, skin .e 678 to 1069 1 to 394       394/394
(100 %)
9 diff
(97.8 %id)
BE218915 carcinoid, lung .e 683 to 1170 488 to 1       488/488
(100 %)
1 diff
(99.8 %id)
AI480021 anaplastic oligodendroglioma, brain .e 697 to 1160 488 to 23   AAA   466/466
(100 %)
3 diff
(99.4 %id)
DA469629   .e 698 to 1254 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AL134494 brain .e 698 to 1265 1 to 570       570/570
(100 %)
9 diff
(98.5 %id)
R53498 breast .e 699 to 949 1 to 251   fully sequenced,   251/251
(100 %)
0 diff
(100 %id)
R73234 breast .e 699 to 949 1 to 252   fully sequenced,   252/252
(100 %)
0 diff
(100 %id)
DB142056 thymus .e 709 to 1234 2 to 529   capped   528/528
(100 %)
2 diff
(99.7 %id)
AI554931 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 711 to 1168 458 to 1       458/458
(100 %)
0 diff
(100 %id)
BQ889403 dorsal root ganglia .e 720 to 1493 1 to 776   tiling clone,   776/786
(98 %)
4 diff
(99.5 %id)
DA074588 cerebellum .e 736 to 1311 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DB252409 uterus .e 736 to 1299 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DR759684 embryonic stem .e 741 to 1595 1 to 855       855/855
(100 %)
8 diff
(99.1 %id)
DA888528   .e 810 to 1362 2 to 554   capped   553/553
(100 %)
3 diff
(99.5 %id)
R53499 breast .e 919 to 1160 242 to 1   fully sequenced,   242/242
(100 %)
0 diff
(100 %id)
R73159 breast .e 919 to 1150 232 to 1   fully sequenced,   232/232
(100 %)
0 diff
(100 %id)
AU153590   .e 2449 to 3004 560 to 1       558/562
(99 %)
18 diff
(96.8 %id)
AA486424   .e 2608 to 3114 503 to 1       503/503
(100 %)
7 diff
(98.7 %id)
AW613749 2 pooled high-grade transitional celltumors, genitourinary tract .e 2627 to 3000 378 to 1       378/378
(100 %)
3 diff
(99.3 %id)
DC426004   .e 2782 to 3314 533 to 1       533/533
(100 %)
0 diff
(100 %id)
AU153238   .e 2784 to 3314 530 to 1       530/532
(99 %)
6 diff
(98.9 %id)
AA356438   .f 1 to 330 1 to 334   tiling clone,   334/334
(100 %)
8 diff
(97.7 %id)
NM_080841.2   .f 79 to 3213 1 to 3135 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3135/3135
(100 %)
0 diff
(100 %id)
X53364   .f 125 to 2683 7 to 2565 E122P tiling clone,   2559/2565
(99 %)
4 diff
(99.9 %id)
AK055787 Kidney .g 1 to 2292 1 to 2292 V87A E468G tiling clone, available from FLJ,   2292/2292
(100 %)
3 diff
(99.9 %id)
NM_080413.1   .g 1 to 2293 1 to 2293 exact RefSeq, AAA   2293/2293
(100 %)
0 diff
(100 %id)
DA624518 Kidney .g 2 to 536 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
CD631483   .g 5 to 741 1 to 735       735/737
(99 %)
11 diff
(98.6 %id)
CR994217 T-Lymphocytes .g 13 to 675 1 to 666       666/697
(95 %)
4 diff
(99.5 %id)
BQ954225 sciatic nerve .g 14 to 859 1 to 853       853/899
(94 %)
16 diff
(98.3 %id)
BM546356 ovary (pool of 3) .g 15 to 857 20 to 863       844/1114
(75 %)
27 diff
(97.6 %id)
BI550033 brain, hippocampus .g 17 to 468 1 to 452       452/452
(100 %)
4 diff
(99.2 %id)
DB137305 thymus .g 17 to 470 2 to 456   capped   455/455
(100 %)
2 diff
(99.6 %id)
CN392795 embryonic stem cells, DMSO-treated H9 cellline .g 18 to 252 1 to 235       235/235
(100 %)
6 diff
(97.5 %id)
BG701461 brain, hippocampus .g 22 to 468 7 to 453       447/453
(98 %)
0 diff
(100 %id)
TI_44169732   .g 22 to 838 84 to 909       826/911
(90 %)
18 diff
(98.1 %id)
DR001389 fetal brain .g 24 to 756 1 to 733       733/733
(100 %)
6 diff
(99.2 %id)
AL537775 brain, fetal brain .g 25 to 930 1 to 904   tiling clone,   904/904
(100 %)
3 diff
(99.7 %id)
BM457709 lymph, lymphoma, cell line .g 25 to 859 1 to 836       836/838
(99 %)
4 diff
(99.6 %id)
CN392796 embryonic stem cells, DMSO-treated H9 cellline .g 26 to 229 1 to 204       204/204
(100 %)
0 diff
(100 %id)
AL530956 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .g 29 to 925 1 to 893       893/893
(100 %)
9 diff
(99.0 %id)
BG760433 melanotic melanoma, high MDR (cell line), skin .g 30 to 845 1 to 813       813/813
(100 %)
7 diff
(99.2 %id)
BG762673 melanotic melanoma, high MDR (cell line), skin .g 30 to 798 1 to 780       780/881
(88 %)
30 diff
(96.6 %id)
CD631486   .g 36 to 885 8 to 857       848/859
(98 %)
16 diff
(98.2 %id)
BX384233   .g 37 to 953 1 to 911       911/984
(92 %)
19 diff
(98.1 %id)
AL558406 T cells from T cell leukemia .g 38 to 900 1 to 862       862/862
(100 %)
6 diff
(99.4 %id)
BG820160 anaplastic oligodendroglioma with 1p/19qloss, brain .g 41 to 744 1 to 703       705/760
(92 %)
14 diff
(98.2 %id)
BQ433948 melanotic melanoma, skin .g 42 to 895 1 to 852       852/857
(99 %)
10 diff
(98.9 %id)
DN992572 brain, whole brain .g 42 to 550 9 to 517       509/517
(98 %)
6 diff
(98.9 %id)
BG438217 large cell carcinoma, lung .g 43 to 568 12 to 553       542/836
(64 %)
32 diff
(96.2 %id)
AW249146 lung, small cell carcinoma .g 44 to 551 10 to 517       508/517
(98 %)
6 diff
(98.9 %id)
BU171458 melanotic melanoma, skin .g 49 to 854 12 to 820       809/867
(93 %)
16 diff
(98.2 %id)
CN392790 embryonic stem cells, cell lines H1, H7, andH9 .g 51 to 521 1 to 471       471/471
(100 %)
0 diff
(100 %id)
BF528208 anaplastic oligodendroglioma with 1p/19qloss, brain .g 51 to 673 1 to 618       618/968
(63 %)
13 diff
(98.7 %id)
BE792870 lung, small cell carcinoma .g 61 to 881 1 to 817       819/941
(87 %)
16 diff
(98.3 %id)
CN392792 embryonic stem cells, cell lines H1, H7, andH9 .g 65 to 762 1 to 698       698/698
(100 %)
4 diff
(99.5 %id)
BM543525 brain, hippocampus .g 65 to 767 20 to 733       714/1094
(65 %)
23 diff
(97.9 %id)
BM012352 brain, neuroblastoma, cell line .g 68 to 816 1 to 756       756/757
(99 %)
35 diff
(95.4 %id)
TI_59381563   .g 69 to 816 105 to 859       755/756
(99 %)
34 diff
(95.6 %id)
CB594727 Blood, promyelocytic leukemia .g 79 to 936 1 to 867       867/871
(99 %)
22 diff
(97.5 %id)
AW246043 lung, small cell carcinoma .g 81 to 564 10 to 494       485/501
(96 %)
16 diff
(96.9 %id)
CD631481   .g 130 to 724 10 to 603       594/603
(98 %)
11 diff
(98.2 %id)
CD631482   .g 130 to 738 610 to 3       608/620
(98 %)
7 diff
(98.9 %id)
BQ943846 large cell carcinoma, lung .g 149 to 949 1 to 806       806/958
(84 %)
19 diff
(98.1 %id)
BF766598 colon_est .g 425 to 676 415 to 164     Submitted on the opposite strand 252/415
(60 %)
0 diff
(100 %id)
BC005885 Lung, small cell carcinoma .g 954 to 2293 1399 to 60   tiling clone, AAA Submitted on the opposite strand 1340/1913
(70 %)
0 diff
(100 %id)
BG281291 melanotic melanoma, skin .g 994 to 1797 1 to 804       804/1010
(79 %)
13 diff
(98.8 %id)
CU449351 epidermis .g 995 to 1542 561 to 14     Submitted on the opposite strand 548/561
(97 %)
0 diff
(100 %id)
BI116933 lung, small cell carcinoma .g 1019 to 1842 1 to 826   available from MGC,   826/828
(99 %)
18 diff
(97.9 %id)
BC021291 Lung, small cell carcinoma .g 1020 to 2293 1 to 1274   available from MGC, AAA   1274/1274
(100 %)
0 diff
(100 %id)
BE795723 lung, small cell carcinoma .g 1034 to 1647 1 to 613       613/613
(100 %)
1 diff
(99.9 %id)
BF970937 adrenal cortex carcinoma, cell line, adrenal gland .g 1085 to 1803 1 to 718       718/718
(100 %)
1 diff
(99.9 %id)
CB149332 Liver .g 1098 to 1447 1 to 350       350/350
(100 %)
1 diff
(99.8 %id)
TI_1520872105   .g 1184 to 2231 50 to 1095       1046/1267
(82 %)
12 diff
(99.1 %id)
TI_1520874101   .g 1184 to 1893 734 to 25       711/1281
(55 %)
1 diff
(100.0 %id)
TI_1520874465   .g 1184 to 2242 43 to 1101       1059/1228
(86 %)
20 diff
(98.4 %id)
BG681429 skin, squamous cell carcinoma .g 1185 to 1982 1 to 802       802/950
(84 %)
21 diff
(97.8 %id)
BC126431 Brain, cerebellum, PCR rescued clones .g 1187 to 2231 1 to 1045       1045/1045
(100 %)
0 diff
(100 %id)
BQ068622 brain, neuroblastoma, cell line .g 1214 to 2147 1 to 945       945/999
(94 %)
38 diff
(96.2 %id)
TI_159723253   .g 1234 to 2293 1121 to 85   AAA   1041/1040
(100 %)
27 diff
(97.5 %id)
BX402035   .g 1243 to 2259 1010 to 1       1010/1010
(100 %)
11 diff
(99.0 %id)
AL566987 brain, fetal brain .g 1246 to 2260 999 to 1       999/1016
(98 %)
22 diff
(97.9 %id)
AL558405 T cells from T cell leukemia .g 1254 to 2234 963 to 1       963/963
(100 %)
31 diff
(96.8 %id)
BG696165 skin .g 1256 to 2140 1 to 893       891/919
(96 %)
39 diff
(95.8 %id)
BC064406 Duodenum, adenocarcinoma .g 1283 to 2293 1 to 1011   available from MGC, AAA   1011/1011
(100 %)
0 diff
(100 %id)
CN392793 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 1313 to 2013 1 to 701       701/701
(100 %)
3 diff
(99.6 %id)
BF973684 leiomyosarcoma cell line, uterus .g 1332 to 1991 1 to 661       661/954
(69 %)
19 diff
(98.1 %id)
BX384232   .g 1336 to 2265 930 to 1       930/1024
(90 %)
8 diff
(99.3 %id)
BQ334072 marrow .g 1352 to 1903 558 to 10       549/558
(98 %)
5 diff
(99.2 %id)
AL530955 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .g 1353 to 2254 898 to 1       898/898
(100 %)
23 diff
(97.5 %id)
BM765517 stomach .g 1384 to 1841 1 to 459       459/459
(100 %)
1 diff
(99.8 %id)
CN392794 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 1412 to 1926 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BG949477 breast .g 1639 to 1863 233 to 6       228/239
(95 %)
12 diff
(95.0 %id)
DB320560 Kidney .g 1789 to 2292 506 to 1       506/506
(100 %)
6 diff
(98.9 %id)
AW250941 lung, small cell carcinoma .g 1890 to 2293 414 to 11   AAA   404/405
(99 %)
0 diff
(100 %id)
AW248718 lung, small cell carcinoma .g 1955 to 2293 349 to 11   AAA   339/339
(100 %)
3 diff
(99.2 %id)
N78898 lung .g 1976 to 2293 330 to 14   AAA   317/317
(100 %)
1 diff
(99.7 %id)
AJ573301 pectoral muscle (after mastectomy) .g 1980 to 2292 1 to 308   AAA   308/308
(100 %)
5 diff
(98.4 %id)
BU175983 eye, retinoblastoma .h 1 to 827 1 to 832   tiling clone,   830/832
(99 %)
5 diff
(99.4 %id)
TI_57163918   .h 690 to 1529 32 to 872   tiling clone,   841/872
(96 %)
11 diff
(98.8 %id)
DB040013 testis .h 1452 to 2025 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
AA910601 leiomyosarcoma, soft tissue .h 1728 to 2381 650 to 3   tiling clone,   650/650
(100 %)
24 diff
(96.4 %id)
DA350167 substantia nigra .h 1761 to 2327 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AK090743 cerebellum .i 1 to 2415 1 to 2413 R9* tiling clone, available from FLJ,   2413/2413
(100 %)
5 diff
(99.8 %id)
AX746597   .i 1 to 2415 1 to 2413 R9*     2413/2413
(100 %)
5 diff
(99.8 %id)
TI_45215546   .j 1 to 795 81 to 883       799/883
(90 %)
17 diff
(98.1 %id)
BI597187 brain, hypothalamus .j 5 to 795 1 to 799   tiling clone,   795/799
(99 %)
16 diff
(98.0 %id)
AB209702 brain .j 17 to 4480 1 to 4465 exact tiling clone,   4465/4465
(100 %)
2 diff
(100.0 %id)
AL133793 amygdala .j 199 to 806 1 to 608   tiling clone,   608/608
(100 %)
0 diff
(100 %id)
DA853508 placenta .j 337 to 912 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
BF334677 colon .j 981 to 1613 635 to 2       634/635
(99 %)
0 diff
(100 %id)
BQ181575 Knee, Osteoarthritic Cartilage .j 4219 to 4887 687 to 17   tiling clone, AAA   671/671
(100 %)
7 diff
(99.0 %id)
BM665333 eye, Retina Foveal and Macular .j 4422 to 4885 480 to 17   AAA   464/469
(98 %)
2 diff
(99.6 %id)
BU733964 eye, Retina Foveal and Macular .j 4422 to 4885 480 to 17   AAA   464/469
(98 %)
2 diff
(99.6 %id)
BM692657 eye, Retina Foveal and Macular .j 4426 to 4884 1 to 459       459/459
(100 %)
2 diff
(99.6 %id)
AI084090 anaplastic oligodendroglioma, brain .j 4464 to 4886 426 to 4       423/426
(99 %)
0 diff
(100 %id)
AI807689 pooled .j 4545 to 4886 344 to 3       342/344
(99 %)
0 diff
(100 %id)
AA652313 normal prostate, Prostate .j 4592 to 5059 466 to 1       466/466
(100 %)
3 diff
(99.4 %id)
T55056 fetal spleen, Spleen .j 4605 to 4895 1 to 304       304/317
(95 %)
18 diff
(94.4 %id)
T54890 fetal spleen, Spleen .j 4615 to 4903 292 to 1       292/350
(83 %)
18 diff
(94.9 %id)
AF147353   .j 4623 to 4903 1 to 281   tiling clone, AAA   281/281
(100 %)
0 diff
(100 %id)
AA652378 normal prostate, Prostate .j 4623 to 5059 436 to 1       436/436
(100 %)
3 diff
(99.4 %id)
AW974713   .j 4704 to 5058 356 to 1     Submitted on the opposite strand 356/381
(93 %)
9 diff
(97.7 %id)
AA653694 normal prostate, Prostate .j 4829 to 5059 231 to 1       231/231
(100 %)
0 diff
(100 %id)
DA646046 mammary gland .j 4874 to 5636 2 to 764   tiling clone, capped   763/769
(99 %)
8 diff
(99.0 %id)
AU147360 mammary gland .j 6107 to 6672 566 to 1   tiling clone,   566/566
(100 %)
9 diff
(98.5 %id)
BF912820 uterus_tumor .k 1 to 181 181 to 1   tiling clone, Submitted on the opposite strand 181/181
(100 %)
2 diff
(98.9 %id)
BC073959 Peripheral Nervous System, dorsal rootganglion .k 133 to 1957 1 to 1825 exact tiling clone, available from MGC, AAA   1825/1825
(100 %)
0 diff
(100 %id)
BU150610 dorsal root ganglia .k 134 to 1062 1 to 930       928/933
(99 %)
8 diff
(99.2 %id)
TI_1948233205   .k 220 to 1000 122 to 901       780/1353
(57 %)
9 diff
(99.4 %id)
TI_1948233353   .k 220 to 1056 123 to 955   fully sequenced,   833/955
(87 %)
12 diff
(98.8 %id)
TI_1948233507   .k 220 to 1083 120 to 981       862/1333
(64 %)
11 diff
(99.2 %id)
TI_1948233663   .k 220 to 1061 118 to 962   fully sequenced,   845/962
(87 %)
9 diff
(99.1 %id)
EL736751 mixed .k 226 to 733 1 to 508       508/508
(100 %)
4 diff
(99.3 %id)
BG682648 skin, squamous cell carcinoma .k 403 to 1205 44 to 851       808/980
(82 %)
19 diff
(98.1 %id)
TI_1948233206   .k 1003 to 1799 924 to 127       798/1186
(67 %)
3 diff
(99.8 %id)
TI_1948233354   .k 1026 to 1799 901 to 126   fully sequenced,   776/901
(86 %)
5 diff
(99.5 %id)
TI_1948233664   .k 1031 to 1799 898 to 129   fully sequenced,   770/898
(85 %)
5 diff
(99.5 %id)
TI_1948233508   .k 1088 to 1799 842 to 128       715/1286
(55 %)
9 diff
(99.4 %id)
CR608865 B cells (Ramos cell line) Cot 25-normalized .l 1 to 2541 1 to 2541 exact tiling clone,   2541/2541
(100 %)
0 diff
(100 %id)
AL515346 neuroblastoma, placenta .l 23 to 1068 1 to 1047       1047/1047
(100 %)
1 diff
(100.0 %id)
AL515345 neuroblastoma, placenta .l 1621 to 2576 954 to 1   tiling clone,   954/954
(100 %)
29 diff
(97.0 %id)
AL534946 brain, fetal brain .m 1 to 1029 1 to 1026 I17X R169X S220X R221G D251X ... tiling clone,   1026/1026
(100 %)
13 diff
(98.8 %id)
AF121183 Liver .m 814 to 1283 1 to 471   tiling clone,   471/487
(96 %)
8 diff
(98.4 %id)
AW996291 breast_normal .m 912 to 1447 535 to 1   tiling clone, Submitted on the opposite strand 535/535
(100 %)
2 diff
(99.7 %id)
CX867440 embryonic stem .m 1053 to 1845 1 to 792   fully sequenced,   792/792
(100 %)
1 diff
(99.9 %id)
AL565716 brain, fetal brain .m 1077 to 2104 1029 to 1       1029/1029
(100 %)
20 diff
(98.1 %id)
AL547613 placenta, Placenta Cot 25-normalized .m 1180 to 2099 1 to 920       920/920
(100 %)
0 diff
(100 %id)
TI_149289109   .m 1223 to 2137 1043 to 145   AAA   901/952
(94 %)
42 diff
(95.6 %id)
TI_154119234   .m 1223 to 2143 998 to 83   tiling clone, AAA   916/992
(92 %)
18 diff
(98.2 %id)
BM544167 ovary (pool of 3) .m 1261 to 1995 13 to 758   available from MGC,   746/1073
(69 %)
25 diff
(97.7 %id)
BC044662 Ovary, pooled from 3 adults .m 1269 to 2137 1 to 869   available from MGC, AAA   869/869
(100 %)
1 diff
(99.9 %id)
TI_2016725581   .m 1280 to 2075 1048 to 253       796/1262
(63 %)
2 diff
(99.9 %id)
BF344754 brain, glioblastoma with EGFR amplification .m 1306 to 2037 1 to 729       729/773
(94 %)
33 diff
(95.8 %id)
BG282668 adenocarcinoma, cell line, Prostate .m 1310 to 2093 1 to 792       790/803
(98 %)
41 diff
(94.9 %id)
BM690338 eye, human retina .m 1340 to 1762 9 to 431   fully sequenced,   423/431
(98 %)
6 diff
(98.7 %id)
BU854834 ovary, teratocarcinoma, cell line .m 1341 to 2136 1 to 799       799/919
(86 %)
15 diff
(98.4 %id)
AW601868 breast .m 1402 to 1929 646 to 119       528/646
(81 %)
3 diff
(99.6 %id)
BG470488 eye, retinoblastoma .m 1429 to 2137 1 to 709   AAA   709/709
(100 %)
0 diff
(100 %id)
BC030571 Uterus, leiomyosarcoma .m 1440 to 2137 12 to 709   available from MGC, AAA   698/698
(100 %)
1 diff
(99.9 %id)
BM468030 leiomyosarcoma, uterus .m 1440 to 2137 31 to 728   available from MGC, AAA   698/728
(95 %)
7 diff
(99.1 %id)
CB242665 Human Lung Epithelial cells, lung .m 1443 to 2137 713 to 19   AAA   695/695
(100 %)
1 diff
(99.9 %id)
CN479639 Knee, Osteoarthritic Cartilage .m 1445 to 2143 717 to 19   AAA   699/699
(100 %)
0 diff
(100 %id)
CA430967 cell lines, Chondrosarcoma .m 1449 to 2137 706 to 19   AAA   688/688
(100 %)
2 diff
(99.8 %id)
BU631234 cell lines, Chondrosarcoma .m 1454 to 2137 702 to 19   AAA   684/688
(99 %)
1 diff
(99.9 %id)
AW104657 ovary, tumor, 5 pooled (see description) .m 1460 to 2137 677 to 1       677/724
(93 %)
18 diff
(97.6 %id)
CB243563 Human Lung Epithelial cells, lung .m 1460 to 2137 695 to 19   AAA   677/691
(97 %)
3 diff
(99.6 %id)
BQ002821 Chondrosarcoma, Left Pelvis .m 1461 to 2137 693 to 19   AAA   675/684
(98 %)
3 diff
(99.6 %id)
AI874233 ovary, tumor, 5 pooled (see description) .m 1463 to 2136 682 to 8       675/682
(98 %)
23 diff
(96.7 %id)
CR999751 T-Lymphocytes .m 1492 to 2116 1 to 627       627/627
(100 %)
2 diff
(99.7 %id)
AI422992 brain, glioblastoma (pooled) .m 1494 to 2136 636 to 3       634/636
(99 %)
12 diff
(98.2 %id)
AI568221 lymph node, lymphoma, follicular mixed small and largecell .m 1517 to 2137 612 to 1       612/616
(99 %)
20 diff
(96.8 %id)
AW070923 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .m 1520 to 2136 614 to 1       614/614
(100 %)
12 diff
(98.1 %id)
AI982720 brain, three pooled meningiomas .m 1545 to 2135 588 to 1       588/588
(100 %)
25 diff
(95.8 %id)
BU620376 cell lines, Chondrosarcoma .m 1548 to 2137 607 to 19   AAA   589/589
(100 %)
1 diff
(99.9 %id)
AI245626 Kidney .m 1577 to 2138 559 to 1       559/565
(98 %)
6 diff
(99.0 %id)
BF333491 colon_normal .m 1599 to 1952 354 to 1       354/354
(100 %)
0 diff
(100 %id)
AA383943 thymus .m 1618 to 1871 1 to 254       254/254
(100 %)
0 diff
(100 %id)
BQ711196 Spleen .m 1618 to 2136 13 to 531   AAA   519/531
(97 %)
6 diff
(98.9 %id)
AA886889 Kidney .m 1625 to 2084 458 to 1       458/458
(100 %)
2 diff
(99.6 %id)
BF914524 uterus_tumor .m 1633 to 1928 302 to 7     Submitted on the opposite strand 296/305
(97 %)
5 diff
(98.4 %id)
AI399730 Prostate .m 1633 to 2138 508 to 1       508/584
(86 %)
18 diff
(97.0 %id)
CA426363 cell lines, Chondrosarcoma .m 1643 to 2137 513 to 19   AAA   495/495
(100 %)
1 diff
(99.8 %id)
AI510735 aorta .m 1662 to 2132 475 to 6       470/475
(98 %)
0 diff
(100 %id)
AI096719 brain, glioblastoma (pooled) .m 1666 to 2136 499 to 29   AAA   471/471
(100 %)
5 diff
(99.0 %id)
AJ346510 pectoral muscle (after mastectomy) .m 1672 to 2109 1 to 438       438/438
(100 %)
7 diff
(98.5 %id)
BU730476 eye, RPE and Choroid .m 1673 to 2137 483 to 19   AAA   465/465
(100 %)
6 diff
(98.8 %id)
BM843294 stomach .m 1679 to 2136 1 to 458       458/458
(100 %)
1 diff
(99.8 %id)
BM855623 stomach .m 1679 to 2098 1 to 420       420/420
(100 %)
0 diff
(100 %id)
AI273187 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m 1690 to 2137 449 to 1       449/449
(100 %)
1 diff
(99.8 %id)
BQ005202 Chondrosarcoma, Left Pelvis .m 1691 to 2137 465 to 19   AAA   447/447
(100 %)
0 diff
(100 %id)
AI091643 pooled .m 1696 to 2138 448 to 6       443/449
(98 %)
0 diff
(100 %id)
BU726865 eye, human retina .m 1701 to 2137 455 to 19   fully sequenced, AAA   437/437
(100 %)
0 diff
(100 %id)
AI245863 Kidney .m 1703 to 2138 440 to 5       436/440
(99 %)
0 diff
(100 %id)
AA573078 breast .m 1706 to 2137 446 to 16   AAA   431/431
(100 %)
1 diff
(99.8 %id)
BF915753 uterus_tumor .m 1731 to 1937 44 to 251       208/251
(82 %)
6 diff
(97.7 %id)
AI801094 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .m 1732 to 2137 434 to 30   AAA   405/405
(100 %)
3 diff
(99.3 %id)
AI826362 normal prostate, Prostate .m 1739 to 2136 403 to 6       398/403
(98 %)
0 diff
(100 %id)
AA455181.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 1757 to 2136 382 to 4     also hits gene PRR4andPRH1andTAS2R14 379/382
(99 %)
0 diff
(100 %id)
BM145653 leukopheresis .m 1759 to 2139 397 to 17   AAA   381/398
(95 %)
10 diff
(97.5 %id)
AI475631 B-cell, chronic lymphotic leukemia .m 1770 to 2137 387 to 20   AAA   368/368
(100 %)
1 diff
(99.8 %id)
AW627753 2 pooled high-grade transitional celltumors, genitourinary tract .m 1778 to 2137 372 to 13   AAA   360/360
(100 %)
0 diff
(100 %id)
BQ018310 lung, Metastatic Chondrosarcoma .m 1778 to 2139 378 to 17   AAA   362/367
(98 %)
1 diff
(99.8 %id)
AJ346807 pectoral muscle (after mastectomy) .m 1781 to 2135 1 to 349       349/349
(100 %)
8 diff
(97.8 %id)
AA492377 Prostate .m 1781 to 2114 340 to 8       333/340
(97 %)
2 diff
(99.5 %id)
AA580425 colon, colon tumor .m 1781 to 2140 362 to 4       359/362
(99 %)
0 diff
(100 %id)
AI207299 placenta .m 1781 to 2140 362 to 4       359/362
(99 %)
0 diff
(100 %id)
BM715129 eye, human retina .m 1787 to 2136 1 to 350   AAA   350/350
(100 %)
0 diff
(100 %id)
AA661625 normal prostate, Prostate .m 1793 to 2137 358 to 15   AAA   344/344
(100 %)
1 diff
(99.8 %id)
AW104714 ovary, tumor, 5 pooled (see description) .m 1793 to 2137 345 to 1       345/345
(100 %)
2 diff
(99.5 %id)
AI886082 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .m 1800 to 2138 343 to 4       340/343
(99 %)
0 diff
(100 %id)
CA307132 Alveolar Macrophage, lung .m 1803 to 2137 352 to 19   AAA   334/338
(98 %)
5 diff
(98.6 %id)
AA688317 normal prostate, Prostate .m 1807 to 2138 332 to 2       331/332
(99 %)
0 diff
(100 %id)
AI082841 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 1835 to 2143 311 to 3       309/314
(98 %)
0 diff
(100 %id)
CX867357 embryonic stem .m 1835 to 2431 626 to 30   tiling clone, fully sequenced, AAA   597/597
(100 %)
1 diff
(99.9 %id)
AI282429 Kidney, renal cell tumor .m 1838 to 2137 300 to 1       300/300
(100 %)
0 diff
(100 %id)
BE242464 leukopheresis .m 1839 to 2139 301 to 1       301/301
(100 %)
2 diff
(99.4 %id)
BG993152 head_neck .m 1857 to 2098 1 to 241       241/295
(81 %)
5 diff
(98.4 %id)
BE206938 lung, small cell carcinoma .m 1862 to 2137 325 to 50   AAA Submitted on the opposite strand 276/276
(100 %)
0 diff
(100 %id)
AW151368 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m 1884 to 1984 102 to 1       102/104
(98 %)
1 diff
(99.1 %id)
AW196725 adenocarcinoma, Pancreas .m 1893 to 2137 273 to 29   AAA   245/245
(100 %)
9 diff
(96.4 %id)
AW135591   .m 1894 to 2136 260 to 18   AAA   243/243
(100 %)
0 diff
(100 %id)
BX094232 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .m 1898 to 2137 254 to 15   AAA   240/240
(100 %)
3 diff
(98.8 %id)
BF751232 breast_normal .m 1900 to 2082 200 to 16     Submitted on the opposite strand 185/201
(92 %)
0 diff
(100 %id)
AW083675 esophagus, squamous cell carcinoma .m 1935 to 2137 222 to 20   AAA   203/203
(100 %)
2 diff
(99.1 %id)
AI874237 ovary, tumor, 5 pooled (see description) .m 1941 to 2136 204 to 7       198/204
(97 %)
0 diff
(100 %id)
BG236423 blood, lymphocyte .m 1941 to 2138 204 to 7       198/205
(96 %)
0 diff
(100 %id)
AW300941 colon, moderately differentiated adenocarcinoma .m 1975 to 2137 195 to 33   AAA   163/163
(100 %)
0 diff
(100 %id)
AI424123 brain, glioblastoma (pooled) .m 1989 to 2136 148 to 1       148/148
(100 %)
1 diff
(99.4 %id)
AA779495   .m 2012 to 2415 407 to 5       403/407
(99 %)
0 diff
(100 %id)
BU753120 placenta .m 2297 to 2797 518 to 18   tiling clone, AAA   501/501
(100 %)
0 diff
(100 %id)
AA485527 ovarian tumor, ovary .m 2588 to 3012 1 to 424       424/424
(100 %)
4 diff
(99.1 %id)
BX109940 ovarian tumor, ovary .m 2589 to 3291 1 to 703   tiling clone, AAA   703/703
(100 %)
0 diff
(100 %id)
BF439479 pooled .m 2732 to 3291 560 to 1       560/560
(100 %)
1 diff
(99.9 %id)
AI743613 pooled .m 2785 to 3291 507 to 1       507/507
(100 %)
3 diff
(99.5 %id)
AI393837 pooled .m 2835 to 3291 457 to 1       457/457
(100 %)
0 diff
(100 %id)
AA485370 ovarian tumor, ovary .m 3040 to 3291 251 to 1       251/251
(100 %)
1 diff
(99.7 %id)
CX163310 human embryonic stem cells differentiated toan early endodermal cell type .n 1 to 876 1 to 876   tiling clone,   876/876
(100 %)
0 diff
(100 %id)
DA915458   .n 13 to 274 2 to 263   capped   262/262
(100 %)
0 diff
(100 %id)
CU449214 epidermis .n 712 to 1183 488 to 18   tiling clone, Submitted on the opposite strand 471/488
(96 %)
8 diff
(98.4 %id)
BG121285 adenocarcinoma, cell line, Liver .o 1 to 782 1 to 781 L155W W158G F177L E216G tiling clone,   781/1116
(69 %)
16 diff
(98.6 %id)
TI_57180610   .p 1 to 778 28 to 805 D15G H17P T19D A20S S21F ... tiling clone,   778/806
(96 %)
17 diff
(97.9 %id)
BI768159 pooled lung and spleen .p 2 to 778 1 to 777 D15G H17P T19D A20S S21F ... tiling clone,   777/778
(99 %)
12 diff
(98.5 %id)
CR626842 fetal brain .q 1 to 1439 1 to 1439 exact tiling clone,   1439/1439
(100 %)
0 diff
(100 %id)
DA638390 Liver .q 281 to 836 2 to 557   capped   556/556
(100 %)
3 diff
(99.5 %id)
BF870896 lung_tumor .q 282 to 684 1 to 404       404/418
(96 %)
11 diff
(97.4 %id)
CR735591 brain, neuroblastoma, cell line .q 355 to 849 38 to 532       495/532
(93 %)
6 diff
(98.9 %id)
BF530576 anaplastic oligodendroglioma with 1p/19qloss, brain .q 370 to 913 53 to 601       549/601
(91 %)
20 diff
(96.7 %id)
BM467458 duodenal adenocarcinoma, cell line, small intestine .q 427 to 905 1 to 479   available from MGC,   479/1449
(33 %)
10 diff
(99.4 %id)
BF851577 lung_normal .q 462 to 907 468 to 26     Submitted on the opposite strand 443/477
(92 %)
20 diff
(95.9 %id)
DB481629 hippocampus .r 1 to 472 1 to 472 exact tiling clone,   472/472
(100 %)
0 diff
(100 %id)
TI_154122927   .s 1 to 810 882 to 78 I2M E3R G4A R5I V6A ... tiling clone, AAA   803/997
(80 %)
15 diff
(98.5 %id)
CN480070 Knee, Osteoarthritic Cartilage .s 129 to 810 699 to 19   tiling clone, AAA   681/681
(100 %)
1 diff
(99.9 %id)
BQ446847 Knee, Osteoarthritic Cartilage .t 1 to 584 609 to 11 K45N S47P K48R S49A K50R ... tiling clone, AAA   591/591
(100 %)
2 diff
(99.7 %id)
DA116217 cerebellum .u-u 1 to 517 2 to 518   tiling clone, to resequence, capped   517/517
(100 %)
0 diff
(100 %id)
AK024387 placenta .u-u 1238 to 4622 1 to 3386 exact tiling clone, available from FLJ,   3386/5020
(67 %)
9 diff
(99.9 %id)
AU140728 placenta .u-u 1239 to 2130 2 to 888   capped   887/887
(100 %)
12 diff
(98.7 %id)
AK024364 placenta .u-u 2513 to 6159 1 to 3648   tiling clone, available from FLJ,   3648/3648
(100 %)
38 diff
(99.0 %id)
AU140134 placenta .u-u 2514 to 3002 2 to 489   capped   488/491
(99 %)
23 diff
(95.4 %id)
BF735227 amnion_normal .u-u 3762 to 3942 182 to 1     Submitted on the opposite strand 182/182
(100 %)
1 diff
(99.5 %id)
BX953127   .u-u 4268 to 4868 1 to 601   tiling clone,   601/601
(100 %)
0 diff
(100 %id)
T39974 Liver .u-u 4322 to 4605 1 to 284       284/284
(100 %)
0 diff
(100 %id)
G65674   .u-u 4352 to 4547 1 to 196       196/196
(100 %)
0 diff
(100 %id)
AA489914   .u-u 5224 to 5666 1 to 444   tiling clone,   444/444
(100 %)
10 diff
(97.8 %id)
DB300204 cerebellum .u-u 5597 to 6159 561 to 1   to resequence,   561/561
(100 %)
4 diff
(99.3 %id)
AU158316 placenta .u-u 5606 to 6159 554 to 1       554/558
(99 %)
9 diff
(98.4 %id)
AA490069   .u-u 5671 to 6158 488 to 1       488/488
(100 %)
3 diff
(99.4 %id)
T40921 Liver .u-u 5859 to 6143 287 to 3       285/287
(99 %)
0 diff
(100 %id)
BX092612   .u-u 5936 to 6173 238 to 1   tiling clone,   238/240
(99 %)
0 diff
(100 %id)
AA595612   .u-u 5955 to 6120 1 to 166       166/166
(100 %)
0 diff
(100 %id)
DA431247 colon .va 1 to 553 2 to 554 exact tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
CB155197 brain .vb 1 to 528 1 to 528 A105X tiling clone,   528/528
(100 %)
0 diff
(100 %id)
DA127712 cerebellum .vb 98 to 397 2 to 301   capped   300/300
(100 %)
1 diff
(99.7 %id)
AA308758 brain, cerebellum .vc-u 1 to 345 1 to 348 V20F E106G D107S P108S tiling clone,   348/348
(100 %)
5 diff
(98.6 %id)
BX472629   .vd 1 to 480 14 to 494 exact tiling clone,   485/494
(98 %)
7 diff
(98.6 %id)
BM693073 eye, Retina Foveal and Macular .ve 1 to 256 1 to 256   tiling clone, fully sequenced,   256/256
(100 %)
0 diff
(100 %id)
DW413714 Liver .ve 27 to 336 10 to 319       310/319
(97 %)
6 diff
(98.2 %id)
BQ575719 Chondrosarcoma Grade II, Left Pelvis .ve 57 to 763 723 to 19 exact AAA   705/705
(100 %)
3 diff
(99.6 %id)
TI_149288216   .ve 119 to 763 778 to 134 Y12F L27F A45G Q67* AAA   645/919
(70 %)
14 diff
(98.5 %id)
BU730199 eye, Retina Foveal and Macular .ve 226 to 763 556 to 19 exact tiling clone, fully sequenced, AAA   538/538
(100 %)
0 diff
(100 %id)
BG989499 head_neck .vf 1 to 591 17 to 606 T8A L29R C33G S34T W38G ... tiling clone,   590/610
(96 %)
20 diff
(96.8 %id)
AK294990 brain .vg 1 to 1047 1 to 1047 exact tiling clone,   1047/1047
(100 %)
0 diff
(100 %id)
BE968649 heart .vh-u 1 to 599 1 to 596   tiling clone,   596/610
(97 %)
5 diff
(99.2 %id)
BI049111 uterus .vh-u 136 to 278 1 to 141       141/142
(99 %)
9 diff
(93.7 %id)
BX645000   .vh-u 531 to 967 1 to 437   tiling clone,   437/437
(100 %)
3 diff
(99.4 %id)
BG681719 skin, squamous cell carcinoma .vh-u 961 to 1723 1 to 765   tiling clone,   765/769
(99 %)
30 diff
(96.1 %id)
BE070400 breast .vh-u 1409 to 1870 1 to 462       462/462
(100 %)
8 diff
(98.3 %id)
BE070198 breast .vh-u 1412 to 2028 16 to 631       616/634
(97 %)
17 diff
(97.4 %id)
BE070465 breast .vh-u 1412 to 1827 11 to 427   tiling clone,   417/427
(97 %)
6 diff
(98.6 %id)
BE070270 breast .vh-u 1419 to 1972 554 to 1   tiling clone, Submitted on the opposite strand 554/554
(100 %)
2 diff
(99.7 %id)
BE070201 breast .vh-u 1444 to 2045 9 to 608       600/610
(98 %)
20 diff
(96.8 %id)
BE070404 breast .vh-u 1501 to 1981 480 to 3     Submitted on the opposite strand 478/480
(99 %)
0 diff
(100 %id)
BE070262 breast .vh-u 1582 to 2173 616 to 28   tiling clone, Submitted on the opposite strand 589/616
(95 %)
0 diff
(100 %id)
BE070272 breast .vh-u 1590 to 2166 578 to 1     Submitted on the opposite strand 578/579
(99 %)
6 diff
(99.0 %id)
BE070493 breast .vh-u 1742 to 2171 429 to 1     Submitted on the opposite strand 429/429
(100 %)
4 diff
(99.1 %id)
BE070395 breast .vh-u 1746 to 2165 418 to 1     Submitted on the opposite strand 418/418
(100 %)
5 diff
(98.9 %id)
AA879430 pooled .vh-u 1938 to 2333 396 to 1   tiling clone,   396/396
(100 %)
0 diff
(100 %id)
BE070484 breast .vh-u 1971 to 2166 1 to 192       192/192
(100 %)
8 diff
(95.9 %id)
BF770221 epid_tumor .vi-u 1 to 377 415 to 39 N13H N21H tiling clone, Submitted on the opposite strand 377/415
(90 %)
0 diff
(100 %id)
BQ711655 Spleen .vi-u 297 to 1137 1 to 850   tiling clone,   850/896
(94 %)
18 diff
(98.0 %id)
DA119316 cerebellum .vj-u 1 to 506 2 to 507 exact tiling clone, capped   506/506
(100 %)
0 diff
(100 %id)
AI141608 liver and spleen .vj-u 312 to 761 450 to 1   tiling clone,   450/450
(100 %)
0 diff
(100 %id)
AA701279 liver and spleen .vj-u 362 to 761 402 to 1       402/406
(99 %)
3 diff
(99.3 %id)
AA701899 liver and spleen .vj-u 456 to 761 306 to 1       306/306
(100 %)
0 diff
(100 %id)
BX481785   .vk-u 1 to 576 8 to 581 V21C L22C L23* tiling clone,   574/593
(96 %)
6 diff
(99.0 %id)
BX643590   .vk-u 6 to 639 1 to 634 exact tiling clone,   634/634
(100 %)
2 diff
(99.7 %id)
BX643894   .vk-u 9 to 685 1 to 677 exact tiling clone,   677/682
(99 %)
10 diff
(98.6 %id)
CV374603 head_neck .vl-u 1 to 188 190 to 1   tiling clone, Submitted on the opposite strand 190/192
(98 %)
11 diff
(94.3 %id)
DB266052 uterus .vl-u 78 to 664 2 to 590 E24* tiling clone, capped   589/589
(100 %)
2 diff
(99.7 %id)
BM706482 eye, eye anterior segment .vm-u 1 to 161 9 to 169 exact tiling clone,   161/169
(95 %)
0 diff
(100 %id)
BM673307 eye, eye anterior segment .vm-u 245 to 642 416 to 19   tiling clone, AAA   398/398
(100 %)
0 diff
(100 %id)
AI872157 ovary, tumor, 5 pooled (see description) .vm-u 267 to 644 397 to 20   AAA   378/378
(100 %)
2 diff
(99.5 %id)
BX505369   .vn-u 1 to 606 1 to 606 T61P tiling clone,   606/606
(100 %)
2 diff
(99.7 %id)
CN350400 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vo 1 to 443 1 to 443 exact tiling clone,   443/443
(100 %)
4 diff
(99.1 %id)
AI651855 pooled germ cell tumors .vp-u 1 to 339 353 to 15 exact tiling clone,   339/353
(96 %)
0 diff
(100 %id)
AW024120 pooled germ cell tumors .vp-u 1 to 345 351 to 8 P11Q M12*     344/351
(98 %)
0 diff
(100 %id)
AI475668 B-cell, chronic lymphotic leukemia .vp-u 121 to 359 239 to 1   tiling clone,   239/239
(100 %)
0 diff
(100 %id)
AW449874   .vp-u 189 to 351 181 to 19   AAA   163/163
(100 %)
10 diff
(93.9 %id)
BF745060 breast .vq-u 1 to 356 17 to 375 E2Q E4K A6V H11R N12E ... tiling clone,   359/375
(95 %)
6 diff
(98.4 %id)
181 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u-u, .va, .vb, .vc-u, .vd, .ve, .vf, .vg, .vh-u, .vi-u, .vj-u, .vk-u, .vl-u, .vm-u, .vn-u, .vo, .vp-u, .vq-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI